Clinical Trial Update: Genetic Mapping for Cardiac Risk Assessment

View source ↗

Summary

An ongoing genetic mapping trial intended to assess cardiac risk. The current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Artery Disease
• Coronary Syndrome
• Myocardial Infarction
• Myocardial Ischemia

Snippet

Sponsor: Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy | Conditions: Angina Pectoris, Myocardial Infarction | Status: UNKNOWN